Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Profit After Tax

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Profit After Tax History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit After Tax ₹1,941 Cr₹130,968 Cr₹1,453 Cr₹129 Cr₹10,561 Cr

What is the latest Profit After Tax of MANKIND PHARMA ?

The latest Profit After Tax ratio of MANKIND PHARMA is ₹1,941 Cr based on Mar2025 Consolidated results.
Year Profit After Tax
Mar2025₹1,941 Cr
Mar2024₹130,968 Cr
Mar2023₹1,453 Cr
Mar2022₹129 Cr
Mar2021₹10,561 Cr

How is Profit After Tax of MANKIND PHARMA Trending?

Years Profit After Tax % Change
Mar2025 ₹1,941 Cr
-98.52
Mar2024 ₹130,968 Cr
8,913.86
Mar2023 ₹1,453 Cr
1,023.68
Mar2022 ₹129 Cr
-98.78
Mar2021 ₹10,561 Cr -

Compare Profit After Tax of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹88,458.9 Cr -1.7% -5.5% -16.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,220.0 Cr 1.2% 2.3% -1.1% Stock Analytics
DIVIS LABORATORIES ₹168,486.0 Cr 0.9% -2.5% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,963.0 Cr 0.5% -1.5% 12.3% Stock Analytics
CIPLA ₹121,751.0 Cr 1.1% -1.6% 4.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,866.0 Cr 2.7% 2.9% 3.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.7%

-5.5%

-16.9%

SENSEX

0.1%

0.9%

4.5%


You may also like the below Video Courses